{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T21:54:09Z","timestamp":1788990849918,"version":"build-2803163510"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2025,5,9]],"date-time":"2025-05-09T00:00:00Z","timestamp":1746748800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,5,9]],"date-time":"2025-05-09T00:00:00Z","timestamp":1746748800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100004375","name":"Tel Aviv University","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100004375","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Assist Reprod Genet"],"published-print":{"date-parts":[[2025,6]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Research question<\/jats:title>\n            <jats:p>Does the use of GnRH agonist trigger versus hCG trigger affect the length of the subsequent follicular phase in women?<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Design<\/jats:title>\n            <jats:p>A retrospective cohort study analyzing 196 women undergoing controlled ovarian stimulation with freeze-all for PGT-M at a university-affiliated fertility center; 132 received GnRH agonist trigger, and 64 received hCG trigger.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>The GnRH agonist group demonstrated a significantly longer subsequent follicular phase compared to the hCG group (18.98\u2009\u00b1\u20093.54 vs. 16.06\u2009\u00b1\u20093.13\u00a0days, <jats:italic>P<\/jats:italic>\u2009&lt;\u2009.001), with extended follicular phase occurring in 90.2% versus 60.9% of cycles (<jats:italic>P<\/jats:italic>\u2009&lt;\u2009.001). Both groups had comparable antral follicle counts (14.52\u2009\u00b1\u20097.71 vs. 13.00\u2009\u00b1\u200915.36, <jats:italic>P<\/jats:italic>\u2009=\u2009.748). Multiple regression analysis identified GnRH agonist trigger as a significant independent predictor of subsequent follicular phase length (coefficient\u2009=\u20094.552, 95% CI: 3.058\u20136.045, <jats:italic>P<\/jats:italic>\u2009&lt;\u2009.001), along with BMI (coefficient\u2009=\u20090.188, 95% CI: 0.019\u20130.357, <jats:italic>P<\/jats:italic>\u2009=\u2009.030). The model explained 31.4% of the variance in follicular phase length (F\u2009=\u20097.516, <jats:italic>P<\/jats:italic>\u2009&lt;\u2009.001). After adjusting for confounding variables, pregnancy rates were comparable between groups (OR\u2009=\u20091.763, 95% CI: 0.798\u20133.505, <jats:italic>P<\/jats:italic>\u2009=\u2009.173).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>The GnRH agonist trigger prolongs the subsequent follicular phase compared to the hCG trigger without compromising pregnancy rates. BMI showed a statistically significant but modest association with follicular phase length that requires further validation. These findings have important implications for optimizing the timing of frozen embryo transfer in subsequent cycles and may facilitate more personalized monitoring protocols.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1007\/s10815-025-03503-8","type":"journal-article","created":{"date-parts":[[2025,5,9]],"date-time":"2025-05-09T06:10:40Z","timestamp":1746771040000},"page":"1917-1924","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Impact of GnRH agonist trigger on subsequent follicular phase length in ART cycles"],"prefix":"10.1007","volume":"42","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2336-155X","authenticated-orcid":false,"given":"Roza","family":"Berkovitz-Shperling","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaara","family":"Libai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shir","family":"Aviv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ben-Yosef","family":"Dalit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Azem","family":"Foad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feferkorn","family":"Ido","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,9]]},"reference":[{"key":"3503_CR1","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1007\/978-1-4939-0659-8_7","volume":"1154","author":"RL Barbieri","year":"2014","unstructured":"Barbieri RL. The endocrinology of the menstrual cycle. Methods Mol Biol. 2014;1154:145\u201369.","journal-title":"Methods Mol Biol"},{"key":"3503_CR2","doi-asserted-by":"publisher","first-page":"100837","DOI":"10.1016\/j.yfrne.2020.100837","volume":"57","author":"AE Herbison","year":"2020","unstructured":"Herbison AE. A simple model of estrous cycle negative and positive feedback regulation of GnRH secretion. Front Neuroendocrinol. 2020;57:100837.","journal-title":"Front Neuroendocrinol"},{"key":"3503_CR3","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1093\/humupd\/dmr008","volume":"17","author":"P Humaidan","year":"2011","unstructured":"Humaidan P, Kol S, Papanikolaou EG. GnRH agonist for triggering of final oocyte maturation: time for a change of practice? Hum Reprod Update. 2011;17:510\u201324.","journal-title":"Hum Reprod Update"},{"key":"3503_CR4","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.fertnstert.2007.02.002","volume":"89","author":"L Engmann","year":"2008","unstructured":"Engmann L, DiLuigi A, Schmidt D, et al. The use of gonadotropin-releasing hormone agonist to induce oocyte maturation after cotreatment with GnRH antagonist in high-risk patients undergoing in vitro fertilization prevents the risk of ovarian hyperstimulation syndrome: a prospective randomized controlled study. Fertil Steril. 2008;89:84\u201391.","journal-title":"Fertil Steril"},{"key":"3503_CR5","first-page":"227","volume":"8","author":"K Leth-Moller","year":"2014","unstructured":"Leth-Moller K, Hammer Jagd S, Humaidan P. The luteal phase after GnRHa trigger-understanding an enigma. Int J Fertil Steril. 2014;8:227\u201334.","journal-title":"Int J Fertil Steril"},{"key":"3503_CR6","first-page":"557","volume":"14","author":"A Alyasin","year":"2016","unstructured":"Alyasin A, Mehdinejadiani S, Ghasemi M. GnRH agonist trigger versus hCG trigger in GnRH antagonist in IVF\/ICSI cycles: a review article. Int J Reprod Biomed. 2016;14:557\u201366.","journal-title":"Int J Reprod Biomed"},{"key":"3503_CR7","first-page":"1805","volume":"37","author":"P Humaidan","year":"2020","unstructured":"Humaidan P, Nelson SM, Kosmas IP, et al. Ovarian hyperstimulation syndrome: pathophysiology and prevention. J Assist Reprod Genet. 2020;37:1805\u201320.","journal-title":"J Assist Reprod Genet"},{"key":"3503_CR8","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1210\/jcem-57-4-792","volume":"57","author":"JD Hoff","year":"1983","unstructured":"Hoff JD, Quigley ME, Yen SS. Hormonal dynamics at midcycle: a reevaluation. J Clin Endocrinol Metab. 1983;57:792\u20136.","journal-title":"J Clin Endocrinol Metab"},{"key":"3503_CR9","doi-asserted-by":"publisher","first-page":"2301","DOI":"10.1007\/s10815-021-02226-w","volume":"38","author":"N Gonen","year":"2021","unstructured":"Gonen N, Yavelsky V, Liberty G, et al. Does gonadotropin-releasing hormone agonist cause luteolysis by inducing apoptosis of the human granulosa-luteal cells? J Assist Reprod Genet. 2021;38:2301\u20135.","journal-title":"J Assist Reprod Genet"},{"key":"3503_CR10","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1016\/j.fertnstert.2013.05.028","volume":"100","author":"HM Fatemi","year":"2013","unstructured":"Fatemi HM, Polyzos NP, van Vaerenbergh I, et al. Early luteal phase endocrine profile is affected by the mode of triggering final oocyte maturation. Fertil Steril. 2013;100:742\u20137.","journal-title":"Fertil Steril"},{"key":"3503_CR11","first-page":"76","volume":"36","author":"JH Check","year":"2009","unstructured":"Check JH, Adelson HG, Lauer C, et al. The effect of length of the follicular phase on pregnancy outcome. Clin Exp Obstet Gynecol. 2009;36:76\u20137.","journal-title":"Clin Exp Obstet Gynecol"},{"key":"3503_CR12","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1186\/s13048-020-00690-z","volume":"13","author":"Y Ying","year":"2020","unstructured":"Ying Y, Liu H, Yu Q, et al. Follicular phase length has no influence on frozen-thawed embryo transfers in natural cycles. J Ovarian Res. 2020;13:87.","journal-title":"J Ovarian Res"},{"key":"3503_CR13","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1016\/j.rbmo.2019.12.007","volume":"40","author":"JB Bakkensen","year":"2020","unstructured":"Bakkensen JB, Brady P, Carusi D, et al. The effect of follicular phase length on cycle outcomes. Reprod Biomed Online. 2020;40:362\u20138.","journal-title":"Reprod Biomed Online"},{"key":"3503_CR14","doi-asserted-by":"publisher","first-page":"1648","DOI":"10.1093\/humrep\/deaa107","volume":"35","author":"J Haas","year":"2020","unstructured":"Haas J, Bassil R, Samara N, et al. GnRH agonist and hCG (dual trigger) versus hCG trigger for final follicular maturation: a double-blind, randomized controlled study. Hum Reprod. 2020;35:1648\u201354.","journal-title":"Hum Reprod"},{"key":"3503_CR15","first-page":"2107","volume":"34","author":"S Santos-Ribeiro","year":"2019","unstructured":"Santos-Ribeiro S, Polyzos NP, Haentjens P, et al. Live birth rates after modified natural cycle compared with high-dose FSH stimulation using GnRH antagonists in poor responders. Hum Reprod. 2019;34:2107\u201313.","journal-title":"Hum Reprod"},{"key":"3503_CR16","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1016\/j.fertnstert.2015.01.034","volume":"103","author":"P Humaidan","year":"2015","unstructured":"Humaidan P, Engmann L, Benadiva C. Luteal phase supplementation after gonadotropin-releasing hormone agonist trigger in fresh embryo transfer: the American versus European approaches. Fertil Steril. 2015;103:879\u201385.","journal-title":"Fertil Steril"},{"key":"3503_CR17","doi-asserted-by":"publisher","first-page":"2529","DOI":"10.1093\/humrep\/det304","volume":"28","author":"S Iliodromiti","year":"2013","unstructured":"Iliodromiti S, Blockeel C, Tremellen KP, et al. Consistent high clinical pregnancy rates and low ovarian hyperstimulation syndrome rates in high-risk patients after GnRH agonist triggering and modified luteal support: a retrospective multicentre study. Hum Reprod. 2013;28:2529\u201336.","journal-title":"Hum Reprod"},{"key":"3503_CR18","first-page":"1398","volume":"106","author":"BC Fauser","year":"2016","unstructured":"Fauser BC. GnRH agonist trigger and the hypothalamic-pituitary-ovarian axis: pushing the limits of physiology. Fertil Steril. 2016;106:1398\u20139.","journal-title":"Fertil Steril"},{"key":"3503_CR19","doi-asserted-by":"publisher","first-page":"580171","DOI":"10.1155\/2014\/580171","volume":"2014","author":"JC Castillo","year":"2014","unstructured":"Castillo JC, Humaidan P, Bernab\u00e9u R. Pharmaceutical options for triggering of final oocyte maturation in ART. Biomed Res Int. 2014;2014:580171.","journal-title":"Biomed Res Int"},{"key":"3503_CR20","first-page":"2143","volume":"30","author":"LH Thomsen","year":"2015","unstructured":"Thomsen LH, Humaidan P, Bungum L, et al. The impact of luteal phase support on gene expression of extracellular matrix protein and adhesion molecules in the human endometrium during the window of implantation following controlled ovarian stimulation with GnRH agonist or hCG triggering. Hum Reprod. 2015;30:2143\u201352.","journal-title":"Hum Reprod"},{"key":"3503_CR21","doi-asserted-by":"publisher","first-page":"2029","DOI":"10.1016\/j.fertnstert.2011.01.163","volume":"95","author":"G Griesinger","year":"2011","unstructured":"Griesinger G, Schultz L, Bauer T, et al. Ovarian hyperstimulation syndrome prevention by gonadotropin-releasing hormone agonist triggering of final oocyte maturation in a gonadotropin-releasing hormone antagonist protocol in combination with a \u201cfreeze-all\u201d strategy: a prospective multicentric study. Fertil Steril. 2011;95:2029\u201333.","journal-title":"Fertil Steril"},{"key":"3503_CR22","first-page":"560","volume":"25","author":"S Santos-Ribeiro","year":"2019","unstructured":"Santos-Ribeiro S, Macklon NS, Polyzos NP. The clinical impact of the endometrial effect of premature progesterone elevation in assisted reproduction: a structured review. Hum Reprod Update. 2019;25:560\u201377.","journal-title":"Hum Reprod Update"},{"key":"3503_CR23","first-page":"2212","volume":"33","author":"G Griesinger","year":"2018","unstructured":"Griesinger G, Blockeel C, Sukhikh GT, et al. Oral dydrogesterone versus intravaginal micronized progesterone gel for luteal phase support in IVF: a randomized clinical trial. Hum Reprod. 2018;33:2212\u201321.","journal-title":"Hum Reprod"}],"container-title":["Journal of Assisted Reproduction and Genetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10815-025-03503-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10815-025-03503-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10815-025-03503-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,3]],"date-time":"2025-07-03T08:47:34Z","timestamp":1751532454000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10815-025-03503-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,9]]},"references-count":23,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,6]]}},"alternative-id":["3503"],"URL":"https:\/\/doi.org\/10.1007\/s10815-025-03503-8","relation":{},"ISSN":["1058-0468","1573-7330"],"issn-type":[{"value":"1058-0468","type":"print"},{"value":"1573-7330","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,9]]},"assertion":[{"value":"23 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This retrospective study was conducted in accordance with the Declaration of Helsinki and was approved by the Institutional Review Board of Assuta Medical Center (approval number TLV-0149\u201320). The requirement for informed consent was waived due to the retrospective nature of the study and the use of de-identified data.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics statement"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}